Home About us Articles Multimedia Search Instructions Reader Login
IF 2017: 1.596 (® Clarivate Analytics)
Total Cites: 7606
Q2 in Medicine, General & Internal
Follow Us
Follow Us
  • Users Online: 227
  • Home
  • Print this page
  • Email this page

  Reader Comments

Year : 2018 | Volume:  131 | Issue Number:  23

ORIGINAL ARTICLE

Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study

Qiu Wei, Huang De-Hui, Hou Shi-Fang, Zhang Mei-Ni, Jin Tao, Dong Hui-Qing, Peng Hua, Zhang Chao-Dong, Zhao Gang, Huang Yi-Ning, Zhou Dong, Wu Wei-Ping, Wang Bao-Jun, Li Ji-Mei, Zhang Xing-Hu, Cheng Yan, Li Hai-Feng, Li Ling, Lu Chuan-Zhen, Zhang Xu, Bu Bi-Tao, Dong Wan-Li, Fan Dong-Sheng, Hu Xue-Qiang, Xu Xian-Hao, for the TOWER Trial Chinese Group

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

Back To Article
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal
 

京ICP备05052599号